Week43, 2023
- **Viruses, illness, and deaths**: Seasonal influenza activity remains low but slightly increasing nationally, with influenza A(H1N1) being the most frequently reported virus. Three pediatric deaths were reported, with one occurring during the 2023-24 season. 0.06% of deaths were attributed to influenza this week, stable from the previous week.  

- **U.S. virologic surveillance**: Of clinical lab positives for influenza, 70.1% were Influenza A and 29.9% were Influenza B. Of public health lab positives, 76.7% were Influenza A (85.7% A(H1N1) and 14.3% A(H3N2)), and 23.3% were Influenza B (all Victoria lineage).  

- **Cumulative hospitalization rate**: The cumulative rate is 0.8 per 100,000, including 0.6 per 100,000 for children and 0.8 per 100,000 for adults.  

- **Trends of deaths attributed to influenza**: 0.06% of deaths were from influenza this week, stable compared to the previous week.  

- **Percentage of Influenza A and Influenza B**: 70.1% of clinical lab positives were Influenza A, and 29.9% were Influenza B. Public health labs show 76.7% as Influenza A and 23.3% as Influenza B.  

- **Novel influenza virus (like COVID-19)**: No novel influenza viruses (e.g., COVID-19 or SARS-CoV-2) were reported this week.  

- **Vaccination trends**: CDC continues to recommend that all individuals aged 6 months and older get an annual flu vaccine.  

- **Outpatient respiratory illness visits**: 2.7% of healthcare visits were for respiratory illness, trending upward but still below the national baseline of 2.9%. Eight of 10 regions showed higher ILI activity, with Region 4 (Southeast) above baseline.  

- **Expectation of flu activity from CDC**: CDC expects flu activity to continue its upward trend.  

- **Other key factors**: Hospital admissions for influenza increased slightly, with 1,607 reported this week. Six jurisdictions show moderate activity, and two report high activity. Multiple respiratory viruses, including RSV and SARS-CoV-2, are co-circulating.